{"id":6842,"date":"2016-04-25T20:56:06","date_gmt":"2016-04-26T00:56:06","guid":{"rendered":"https:\/\/mutualisation.ca\/en\/?page_id=6842"},"modified":"2016-04-27T15:25:25","modified_gmt":"2016-04-27T19:25:25","slug":"information-bulletin-2011-5","status":"publish","type":"page","link":"https:\/\/staging.mutualisation.ca\/en\/information-bulletin-2011-5\/","title":{"rendered":"Information Bulletin No. 2011 \u2013 5"},"content":{"rendered":"<p>[vc_row content_width=&#8221;grid&#8221;][vc_column][vc_column_text]For insurers and administrators of employee benefit plans[\/vc_column_text][\/vc_column][\/vc_row][vc_row content_width=&#8221;grid&#8221;][vc_column][vc_column_text]<\/p>\n<p style=\"text-align: justify;\">Ed. Note: this information bulletin does not have the force of law. It represents the point of view of the Quebec Drug Insurance Pooling Corporation on various subjects, based on the Act Respecting Prescription Drug Insurance.<\/p>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space][\/vc_column][\/vc_row][vc_row content_width=&#8221;grid&#8221;][vc_column][vc_text_separator title=&#8221;Explanation of Recent Changes in the Parameters of the Risk Pooling System &#8220;][\/vc_column][\/vc_row][vc_row content_width=&#8221;grid&#8221;][vc_column el_class=&#8221;pie&#8221;][vc_column_text css=&#8221;.vc_custom_1461631995764{border-bottom-width: 1px !important;padding-bottom: 20px !important;border-bottom-color: #e4e4e4 !important;border-bottom-style: solid !important;}&#8221;]<\/p>\n<p style=\"text-align: justify;\">The legislative amendments made to the Act Respecting Prescription Drug Insurance in 2006 were the opportunity for the Quebec Drug Insurance Pooling Corporation to make a survey of private individual and group insurance plans and non-insured employee benefit plans in effect in Quebec which offered drug insurance coverage. The addition to the Act Respecting Prescription Drug Insurance of the new sections 15.1, 42.1 and 42.2 meant that new groups might become subject to the requirement to pool the risks arising from prescription drug costs and that the composition of certain groups already participating in pooling could be changed.<\/p>\n<p style=\"text-align: justify;\">With an eye to ensuring that the pooling system remains fair and continues to have the industry\u2019s support, the Quebec Drug Insurance Pooling Corporation undertook an in-depth review of the terms and conditions of pooling. This review made it clear that the pooling model needed to be adjusted in order to meet the industry\u2019s current needs more closely. This bulletin explains these changes.<\/p>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space][\/vc_column][\/vc_row][vc_row content_width=&#8221;grid&#8221;][vc_column el_class=&#8221;pie&#8221;][vc_column_text]<\/p>\n<h6 style=\"text-align: justify;\">Looking back at the observed facts used for setting up the terms and<br \/>\nconditions of pooling in 1996<\/h6>\n<p>The facts identified and used in 1996 to set up the terms and conditions of pooling were 1) that large groups had the financial ability to assume all inherent risks for medication costs or could protect themselves through pooling formulas negotiated with their insurer; 2) that only small groups were vulnerable to fluctuations in claims; and 3) that pooling would not create an increase in premiums for private plans, but would level out the effect of poor risks over a broader population.<\/p>\n<p>Therefore, the hypotheses used in setting up the terms and conditions of pooling were:<\/p>\n<p>&nbsp;<\/p>\n<div class=\"list\">1. Pooling applies to drug costs that exceed a pre-determined pooling threshold and is done on the basis of certificates, with a certificate signifying an employee and all his dependants (if the latter are covered by the plan);<\/div>\n<div class=\"list\">2. Reaching the threshold is based on the total of claimed medication costs that are eligible under the contract issued by the insurer or the administrator of the employee benefit plan; and<\/div>\n<div class=\"list\">3. The extent of pooling is set according to a group&#8217;s capacity to absorb an increase in premium<\/div>\n<div class=\"list\"><\/div>\n<div class=\"list\"><\/div>\n<p>[\/vc_column_text][vc_column_text]<\/p>\n<p style=\"text-align: justify;\">Since its creation, the risk pooling system has been reviewed annually by the Quebec Drug Insurance Corporation (the Corporation) and the parameters adjusted as necessary. But like any field, the business context for the life and health insurance industry has evolved, and the facts observed in 1996 no longer reflect current reality.<\/p>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space][\/vc_column][\/vc_row][vc_row content_width=&#8221;grid&#8221;][vc_column][eltdf_tabs tabs_layout=&#8221;eltdf-tabs-regular&#8221;][eltdf_tab title=&#8221;The current situation&#8221;][vc_column_text]In drawing up a new risk pooling model, the Corporation still seeks to meet the system\u2019s original objectives. These are to meet the requirements of the Act Respecting Prescription Drug Insurance and of the industry, to reflect the new reality of costs, and to facilitate pooling through fair and robust processes that are not open to misinterpretations or abuse.<\/p>\n<p>In order to meet its objectives<sup>1<\/sup>, the Corporation reviewed its findings, in 2008-2009, in order to improve the existing pooling system. As a result of this exercise, the Coporation made the following observations:<\/p>\n<div class=\"list\">1. The number of major claims has increased.<\/div>\n<div class=\"list\">2. To the impact of major claims and to an ageing population, we must add inflation and an increased use of medications.<\/div>\n<div class=\"list\">3. A small insurer does not have a the financial capacity to respond to the demande for stop-loss protection.<\/div>\n<div class=\"list\">4. The 20% Test, introduced as a barometer to establish the maximum level of pooling<\/div>\n<div class=\"list\">5. The effectiveness of the current risk pooling process has been questioned within the Coporation and the industry.<\/div>\n<div class=\"list\">6. The pan-Canadian context has evolved.<\/div>\n<p>[\/vc_column_text][\/eltdf_tab][\/eltdf_tabs][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space][\/vc_column][\/vc_row][vc_row content_width=&#8221;grid&#8221;][vc_column][eltdf_tabs tabs_layout=&#8221;eltdf-tabs-regular&#8221;][eltdf_tab title=&#8221;The 20% Test&#8221;][\/eltdf_tab][\/eltdf_tabs][\/vc_column][\/vc_row][vc_row content_width=&#8221;grid&#8221;][vc_column width=&#8221;1\/2&#8243;][vc_column_text]Since 1996, the 20% Test has sought to ensure that the groups subject to risk pooling, no matter what their size, would not experience an increase in supplementary health insurance premiums of more than 20% before inflation as a result of a single claim for drug costs above the pooling threshold. This test, simulating a contract renewal, is applied when the pooling factors are determined, in order to confirm that\u00a0the proposed parameters comply with the rule. It is important to state that no consideration is given to price reductions somtimes granted by insurers when submissions are made.[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_column_text]<\/p>\n<p style=\"text-align: justify;\">In practice, the 20% Test mainly makes it possible to say that the current pooling process and the terms and conditions arising from it have been established using hypotheses and scenarios that include a test for reasonability in rate increases.<\/p>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row content_width=&#8221;grid&#8221;][vc_column][vc_empty_space height=&#8221;13px&#8221;][vc_column_text]Based on the observations identified in 2008 and 2009, the parameters of the 20% Test were updated as follows:<\/p>\n<div class=\"list\"><i class=\"eltdf-icon-font-awesome fa fa-chevron-right eltdf-icon-element\"><\/i> The proportion of certificates expected to present a claim was judged to be too low and was adjusted from 62.5% to 80% to reflect a recent market analysis.<\/div>\n<div class=\"list\"><i class=\"eltdf-icon-font-awesome fa fa-chevron-right eltdf-icon-element\"><\/i> The calculation that is made takes into account total premiums paid and an average claim per certificated. Note that this average claim is no longer adjusted as if it were an average claim per individual, since the effect of that method was to overestimate the premium.<\/div>\n<div class=\"list\"><i class=\"eltdf-icon-font-awesome fa fa-chevron-right eltdf-icon-element\"><\/i> Consistent with industry practice, a credibility factor is given to the plan\u2019s experience, based on group size. The credibility formula used is the following: the square root of the number of certificates divided by 75. This formula was created based on a poll of insurers participating in pooling.<\/div>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space][\/vc_column][\/vc_row][vc_row content_width=&#8221;grid&#8221;][vc_column][eltdf_tabs tabs_layout=&#8221;eltdf-tabs-regular&#8221;][eltdf_tab title=&#8221;Changes that were made&#8221;][vc_column_text]After consulting with the participants in the pooling process and the following an in-depth review, the Corporation believes that the pooling system should be slightly adapted to the current market.<br \/>\nThefore, the conditions specific to plans of less than 250 certificates remain:<\/p>\n<div class=\"list\"><i class=\"eltdf-icon-font-awesome fa fa-chevron-right eltdf-icon-element\"><\/i> Groups of fewer than 10 certificates and of 10 to 24 certificates are combined.<\/div>\n<div class=\"list\"><i class=\"eltdf-icon-font-awesome fa fa-chevron-right eltdf-icon-element\"><\/i> Medications eligible for pooling remain those covered by the private plan.<\/div>\n<div class=\"list\">\n<p><i class=\"eltdf-icon-font-awesome fa fa-chevron-right eltdf-icon-element\"><\/i> The compensation formula, based on repetition of risk, remains a layered &#8220;pyramidal&#8221; formula which makes it impossible to avoid forcing a given size of group to absorb an unusual volume of large claims. Rather, claims are shared across the entire pooled population.<\/p>\n<p>Hoewever, the conditions specific to plans of 250 certificates and over become as follows:<\/p>\n<\/div>\n<p>[\/vc_column_text][\/eltdf_tab][\/eltdf_tabs][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space][\/vc_column][\/vc_row][vc_row content_width=&#8221;grid&#8221;][vc_column width=&#8221;1\/2&#8243;][vc_column_text]<\/p>\n<h6>For plans of 250 to 1,499 certificates<\/h6>\n<div class=\"list\"><i class=\"eltdf-icon-font-awesome fa fa-chevron-right eltdf-icon-element\"><\/i> As before, only costs covered by the basic plan are pooled;<\/div>\n<div class=\"list\"><i class=\"eltdf-icon-font-awesome fa fa-chevron-right eltdf-icon-element\"><\/i> Beginning in January 1, 2011 however, pooling will be extended to non-insured employee benefit plans of the Administrative Service Only (ASO) type; and<\/div>\n<div class=\"list\"><i class=\"eltdf-icon-font-awesome fa fa-chevron-right eltdf-icon-element\"><\/i> Group sizes will be modified to include non-insured plans of up to 1,499 certificates.<\/div>\n<p>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_column_text]<\/p>\n<h6>For plans of 1,500 certificates and over<\/h6>\n<div class=\"list\">\n<p><i class=\"eltdf-icon-font-awesome fa fa-chevron-right eltdf-icon-element\"><\/i> These plans will be left to the free market. Pooling does not apply to insured or non-insured plans of this size.[\/vc_column_text][\/vc_column][\/vc_row][vc_row content_width=&#8221;grid&#8221;][vc_column][vc_column_text]The compensation formula remains at 80% of claimed drug costs above the pooling threshold, up to a maximum annual disbursem ent. Once the maximum is reached, compensation increases to 100% of the amount exceeding the threshold. Pooling\u00a0thresholds have been established so that rate increases for a group with poor experience following a very large claim will be less than 20% before inflation in the cost of medications. The target loss index remains at 90%.<\/p>\n<p>It is particularly in order to maintain the industry\u2019s support while responding to the requirements of the Act Respecting Prescription Drug Insurance that the Corporation annually examines how group insurers and administrators of employee benefit plans should fulfill their obligations with respect to pooling. The pooling model that was set up in 1996 is flexible and its preservation is closely linked to the collaboration of all participants.[\/vc_column_text][vc_column_text]C\u2019est notamment dans un souci de maintien de l\u2019adh\u00e9sion de l\u2019industrie au syst\u00e8me de mise en commun des risques et de conformit\u00e9 aux exigences de la Loi, que la Soci\u00e9t\u00e9 se questionne annuellement sur la fa\u00e7on, pour les assureurs en assurance collective et pour les administrateurs de r\u00e9gimes d\u2019avantages sociaux, de remplir l\u2019obligation de mutualisation qui leur incombe. Le m\u00e9canisme de mise en commun \u00e9labor\u00e9 en 1996 est souple et sa pr\u00e9servation est \u00e9troitement li\u00e9e \u00e0 la collaboration de tous les participants.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space][\/vc_column][\/vc_row][vc_row content_width=&#8221;grid&#8221;][vc_column][eltdf_tabs tabs_layout=&#8221;eltdf-tabs-regular&#8221;][eltdf_tab title=&#8221;In the next issue&#8221;][vc_column_text]In the Corporation\u2019s <a href=\"\/information-bulletin-2011-6\/\">Information Bulletin No. 2011 \u2013 6<\/a>, read about \u201cCommunicating the pooling parameters to clients\u201d.[\/vc_column_text][\/eltdf_tab][\/eltdf_tabs][\/vc_column][\/vc_row][vc_row content_width=&#8221;grid&#8221;][vc_column][vc_empty_space][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n<\/div>\n<p>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row content_width=&#8221;grid&#8221;][vc_column][vc_column_text]For insurers and administrators of employee benefit plans[\/vc_column_text][\/vc_column][\/vc_row][vc_row content_width=&#8221;grid&#8221;][vc_column][vc_column_text] Ed. Note: this information bulletin does not have the force of law. It represents the point of view of the Quebec Drug Insurance Pooling Corporation on various subjects, based on the Act Respecting Prescription Drug Insurance. [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space][\/vc_column][\/vc_row][vc_row content_width=&#8221;grid&#8221;][vc_column][vc_text_separator title=&#8221;Explanation of Recent Changes in the Parameters [&hellip;]<\/p>\n","protected":false},"author":22,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"full-width.php","meta":{"footnotes":""},"class_list":["post-6842","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Information Bulletin No. 2011 \u2013 5 - SOCI\u00c9T\u00c9 DE COMPENSATION EN ASSURANCE M\u00c9DICAMENTS DU QU\u00c9BEC<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/staging.mutualisation.ca\/en\/information-bulletin-2011-5\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Information Bulletin No. 2011 \u2013 5 - SOCI\u00c9T\u00c9 DE COMPENSATION EN ASSURANCE M\u00c9DICAMENTS DU QU\u00c9BEC\" \/>\n<meta property=\"og:description\" content=\"[vc_row content_width=&#8221;grid&#8221;][vc_column][vc_column_text]For insurers and administrators of employee benefit plans[\/vc_column_text][\/vc_column][\/vc_row][vc_row content_width=&#8221;grid&#8221;][vc_column][vc_column_text] Ed. Note: this information bulletin does not have the force of law. It represents the point of view of the Quebec Drug Insurance Pooling Corporation on various subjects, based on the Act Respecting Prescription Drug Insurance. [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space][\/vc_column][\/vc_row][vc_row content_width=&#8221;grid&#8221;][vc_column][vc_text_separator title=&#8221;Explanation of Recent Changes in the Parameters [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staging.mutualisation.ca\/en\/information-bulletin-2011-5\/\" \/>\n<meta property=\"og:site_name\" content=\"SOCI\u00c9T\u00c9 DE COMPENSATION EN ASSURANCE M\u00c9DICAMENTS DU QU\u00c9BEC\" \/>\n<meta property=\"article:modified_time\" content=\"2016-04-27T19:25:25+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/staging.mutualisation.ca\\\/en\\\/information-bulletin-2011-5\\\/\",\"url\":\"https:\\\/\\\/staging.mutualisation.ca\\\/en\\\/information-bulletin-2011-5\\\/\",\"name\":\"Information Bulletin No. 2011 \u2013 5 - SOCI\u00c9T\u00c9 DE COMPENSATION EN ASSURANCE M\u00c9DICAMENTS DU QU\u00c9BEC\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/staging.mutualisation.ca\\\/#website\"},\"datePublished\":\"2016-04-26T00:56:06+00:00\",\"dateModified\":\"2016-04-27T19:25:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/staging.mutualisation.ca\\\/en\\\/information-bulletin-2011-5\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/staging.mutualisation.ca\\\/en\\\/information-bulletin-2011-5\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/staging.mutualisation.ca\\\/en\\\/information-bulletin-2011-5\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/staging.mutualisation.ca\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Information Bulletin No. 2011 \u2013 5\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/staging.mutualisation.ca\\\/#website\",\"url\":\"https:\\\/\\\/staging.mutualisation.ca\\\/\",\"name\":\"SOCI\u00c9T\u00c9 DE COMPENSATION EN ASSURANCE M\u00c9DICAMENTS DU QU\u00c9BEC\",\"description\":\"Une entit\u00e9 priv\u00e9e qui rel\u00e8ve de l\u2019industrie des assurances de personnes.\",\"publisher\":{\"@id\":\"https:\\\/\\\/staging.mutualisation.ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/staging.mutualisation.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/staging.mutualisation.ca\\\/#organization\",\"name\":\"Soci\u00e9t\u00e9 de compensation en assurance m\u00e9dicaments du Qu\u00e9bec\",\"url\":\"https:\\\/\\\/staging.mutualisation.ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/staging.mutualisation.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/staging.mutualisation.ca\\\/wp-content\\\/uploads\\\/2016\\\/07\\\/sticky-icon.png\",\"contentUrl\":\"https:\\\/\\\/staging.mutualisation.ca\\\/wp-content\\\/uploads\\\/2016\\\/07\\\/sticky-icon.png\",\"width\":64,\"height\":55,\"caption\":\"Soci\u00e9t\u00e9 de compensation en assurance m\u00e9dicaments du Qu\u00e9bec\"},\"image\":{\"@id\":\"https:\\\/\\\/staging.mutualisation.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Information Bulletin No. 2011 \u2013 5 - SOCI\u00c9T\u00c9 DE COMPENSATION EN ASSURANCE M\u00c9DICAMENTS DU QU\u00c9BEC","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/staging.mutualisation.ca\/en\/information-bulletin-2011-5\/","og_locale":"en_US","og_type":"article","og_title":"Information Bulletin No. 2011 \u2013 5 - SOCI\u00c9T\u00c9 DE COMPENSATION EN ASSURANCE M\u00c9DICAMENTS DU QU\u00c9BEC","og_description":"[vc_row content_width=&#8221;grid&#8221;][vc_column][vc_column_text]For insurers and administrators of employee benefit plans[\/vc_column_text][\/vc_column][\/vc_row][vc_row content_width=&#8221;grid&#8221;][vc_column][vc_column_text] Ed. Note: this information bulletin does not have the force of law. It represents the point of view of the Quebec Drug Insurance Pooling Corporation on various subjects, based on the Act Respecting Prescription Drug Insurance. [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space][\/vc_column][\/vc_row][vc_row content_width=&#8221;grid&#8221;][vc_column][vc_text_separator title=&#8221;Explanation of Recent Changes in the Parameters [&hellip;]","og_url":"https:\/\/staging.mutualisation.ca\/en\/information-bulletin-2011-5\/","og_site_name":"SOCI\u00c9T\u00c9 DE COMPENSATION EN ASSURANCE M\u00c9DICAMENTS DU QU\u00c9BEC","article_modified_time":"2016-04-27T19:25:25+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/staging.mutualisation.ca\/en\/information-bulletin-2011-5\/","url":"https:\/\/staging.mutualisation.ca\/en\/information-bulletin-2011-5\/","name":"Information Bulletin No. 2011 \u2013 5 - SOCI\u00c9T\u00c9 DE COMPENSATION EN ASSURANCE M\u00c9DICAMENTS DU QU\u00c9BEC","isPartOf":{"@id":"https:\/\/staging.mutualisation.ca\/#website"},"datePublished":"2016-04-26T00:56:06+00:00","dateModified":"2016-04-27T19:25:25+00:00","breadcrumb":{"@id":"https:\/\/staging.mutualisation.ca\/en\/information-bulletin-2011-5\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staging.mutualisation.ca\/en\/information-bulletin-2011-5\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/staging.mutualisation.ca\/en\/information-bulletin-2011-5\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/staging.mutualisation.ca\/en\/"},{"@type":"ListItem","position":2,"name":"Information Bulletin No. 2011 \u2013 5"}]},{"@type":"WebSite","@id":"https:\/\/staging.mutualisation.ca\/#website","url":"https:\/\/staging.mutualisation.ca\/","name":"SOCI\u00c9T\u00c9 DE COMPENSATION EN ASSURANCE M\u00c9DICAMENTS DU QU\u00c9BEC","description":"Une entit\u00e9 priv\u00e9e qui rel\u00e8ve de l\u2019industrie des assurances de personnes.","publisher":{"@id":"https:\/\/staging.mutualisation.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.mutualisation.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/staging.mutualisation.ca\/#organization","name":"Soci\u00e9t\u00e9 de compensation en assurance m\u00e9dicaments du Qu\u00e9bec","url":"https:\/\/staging.mutualisation.ca\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/staging.mutualisation.ca\/#\/schema\/logo\/image\/","url":"https:\/\/staging.mutualisation.ca\/wp-content\/uploads\/2016\/07\/sticky-icon.png","contentUrl":"https:\/\/staging.mutualisation.ca\/wp-content\/uploads\/2016\/07\/sticky-icon.png","width":64,"height":55,"caption":"Soci\u00e9t\u00e9 de compensation en assurance m\u00e9dicaments du Qu\u00e9bec"},"image":{"@id":"https:\/\/staging.mutualisation.ca\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/staging.mutualisation.ca\/en\/wp-json\/wp\/v2\/pages\/6842","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staging.mutualisation.ca\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/staging.mutualisation.ca\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/staging.mutualisation.ca\/en\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/staging.mutualisation.ca\/en\/wp-json\/wp\/v2\/comments?post=6842"}],"version-history":[{"count":5,"href":"https:\/\/staging.mutualisation.ca\/en\/wp-json\/wp\/v2\/pages\/6842\/revisions"}],"predecessor-version":[{"id":7398,"href":"https:\/\/staging.mutualisation.ca\/en\/wp-json\/wp\/v2\/pages\/6842\/revisions\/7398"}],"wp:attachment":[{"href":"https:\/\/staging.mutualisation.ca\/en\/wp-json\/wp\/v2\/media?parent=6842"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}